Lineage dependency and lineage-survival oncogenes in human cancer

Area of Science:

• Oncology
• Genomics
• Molecular Biology

Background:

• Traditional cancer classification relies on cell-lineage and differentiation models.
• Emerging evidence recognizes cancer as a genomic disease, necessitating molecular criteria for classification.
• Integrating lineage and genetic insights may reveal novel therapeutic vulnerabilities.

Purpose of the Study:

• To explore the interplay between cancer lineage and genetic alterations.
• To identify new mechanisms of tumor dependency affected by genetic changes.
• To investigate the role of lineage-survival genes in cancer.

Main Methods:

• Review of recent evidence synthesizing lineage-based and genetic paradigms in cancer.
• Analysis of the role of master regulators like MITF in specific genetic contexts.
• Examination of lineage dependency as a mechanism influenced by tumor genetics.

Main Results:

• The integration of lineage and genetic approaches offers new insights into tumor dependencies.
• Microphthalmia-associated transcription factor (MITF), a melanocyte regulator, can act as a melanoma oncogene.
• Tumor genetic alterations affect lineage dependency, a newly recognized mechanism.

Conclusions:

• Lineage dependency, or "addiction," is a crucial concept in understanding cancer.
• MITF and other lineage-survival genes exemplify how genetic alterations impact lineage addiction.
• This synthesis provides a framework for novel therapeutic strategies targeting tumor dependencies.